Method of treating ovarian and renal cancer using antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen

Details for Australian Patent Application No. 2006315580 (hide)

Owner CuraGen Corporation

Inventors Lichenstein, Henri; Shenoy, Suresh G.; Pollack, Vincent A.; Larochelle, William J.; Mansfield, Traci; Tse, Kam Fai; Jeffers, Michael E.; MacDougall, John

Agent Cullen & Co

Pub. Number AU-A-2006315580

PCT Pub. Number WO2007/059082

Priority 60/735,574 10.11.05 US

Filing date 13 November 2006

Wipo publication date 24 May 2007

International Classifications

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/059082 Priority application(s): WO2007/059082

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315592-Methods for prediction and prognosis of cancer, and monitoring cancer therapy

2006315577-Multilayer composite structure with epoxide containing adhesive layer